Literature DB >> 1089822

Report of the Committee for the Assessment of Biometric Aspects of Controlled Trials of Hypoglycemic Agents.

.   

Abstract

Mesh：

Substances：

Year:  1975        PMID： 1089822

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  An ABC of drug-related problems.

Authors:  R H Meyboom; M Lindquist; A C Egberts
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

2.  Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study.

Authors:  Scot H Simpson; Sumit R Majumdar; Ross T Tsuyuki; Dean T Eurich; Jeffrey A Johnson
Journal:  CMAJ       Date:  2006-01-17       Impact factor: 8.262

3.  Rolling boulders and prescribing pills: caring for diabetic patients.

Authors:  A T Evans
Journal:  J Gen Intern Med       Date:  1989 Mar-Apr       Impact factor: 5.128

Review 4.  Oral hypoglycaemic drugs: clinical pharmacology and therapeutic use.

Authors:  J M Stowers; L J Borthwick
Journal:  Drugs       Date:  1977-07       Impact factor: 9.546

5.  Epidemiology in wonderland: Big Data and precision medicine.

Authors:  Rodolfo Saracci
Journal:  Eur J Epidemiol       Date:  2018-04-05       Impact factor: 8.082

6.  The crux of the UGDP. Spurious results and biologically inappropriate data analysis.

Authors:  C Kilo; J P Miller; J R Williamson
Journal:  Diabetologia       Date:  1980-03       Impact factor: 10.122

Review 7.  Oral antidiabetic drug use in the elderly.

Authors:  R Bressler; D G Johnson
Journal:  Drugs Aging       Date:  1996-12       Impact factor: 3.923

Review 8.  Cardiovascular effects of sulphonylurea derivatives. Implications for the treatment of NIDDM?

Authors:  P Smits; T Thien
Journal:  Diabetologia       Date:  1995-01       Impact factor: 10.122

9.  Prevention of coronary heart disease. Report of a Joint Working Party of the Royal College of Physicians of London and the British Cardiac Society.

Authors: 
Journal:  J R Coll Physicians Lond       Date:  1976-04

10.  Therapeutic Drug Monitoring, Electronic Health Records, and Pharmacokinetic Modeling to Evaluate Sirolimus Drug Exposure-Response Relationships in Renal Transplant Patients.

Authors:  Kanecia O Zimmerman; Huali Wu; Rachel Greenberg; Jeffrey T Guptill; Kevin Hill; Uptal D Patel; Lawrence Ku; Daniel Gonzalez; Christoph Hornik; Wenlei Jiang; Nan Zheng; Chiara Melloni; Michael Cohen-Wolkowiez
Journal:  Ther Drug Monit       Date:  2016-10       Impact factor: 3.118
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.